December 9, 2009
Androgen Receptor Antagonists: Lead Optimization and Preclinical PharmacologyAndrogen Receptor Antagonists: Lead Optimization and Preclinical Pharmacology Ashvin V. Gavai, Ph.D. Bristol-Myers Squibb Oncology Chemistry Princeton, NJ Babbio 321, 2:00 P.M. For more information, please contact:
Joseph Glavy Assistant Professor, Chemical Biology McLean Room 314 Phone: 201.216.8193 Fax: 201.216.8196 jglavy@stevens.edu |